Is MEDOF or DGRO a better dividend investment in 2026?

MEDOF currently yields 4.00% with a 5% 5-year dividend growth rate. DGRO yields 2.10% with 9.5% growth. The better choice depends on your goal: MEDOF offers higher current income.

What is the dividend yield difference between MEDOF and DGRO?

MEDOF has a forward dividend yield of 4.00% ($2.00/share annually). DGRO yields 2.10% ($1.47/share annually). The yield gap is 1.90 percentage points.

Home › Compare › MEDOF vs DGRO

MEDOF vs DGRO: Dividend Comparison 2026

MEDOF yields 4.00% · DGRO yields 2.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DGRO wins by $5.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDOF

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$517.11

Full MEDOF calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.10%

Share price

$70.18

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$235.38

Full DGRO calculator →

Portfolio growth — MEDOF vs DGRO

📍 DGRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDOF	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDOF + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDOF pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDOF

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$439.54/yr

DGRO

Annual income on $10K today (after 15% tax)

$178.14/yr

After 10yr DRIP, annual income (after tax)

$200.07/yr

At 15% tax rate, MEDOF beats the other by $239.47/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDOF + DGRO for your $10,000?

MEDOF: 50%DGRO: 50%

100% DGRO50/50100% MEDOF

Portfolio after 10yr

$28.8K

Annual income

$376.25/yr

Blended yield

1.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MEDOF right now

MEDOF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.2

Piotroski

5/9

DGRO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDOF buys

DGRO buys

Politician	Chamber	Ticker	Type	Amount	Date
Scott Mr Franklin	🏢 House	$DGRO	▼ Sell	$15,001 - $50,000	2024-08-06
Kevin Hern	🏢 House	$DGRO	▲ Buy	$1,001 - $15,000	2022-09-30
Kevin Hern	🏢 House	$DGRO	▲ Buy	$1,001 - $15,000	2021-09-30
Kevin Hern	🏢 House	$DGRO	▲ Buy	$250,001 - $500,000	2021-07-01
K. Michael Conaway	🏢 House	$DGRO	▲ Buy	$50,001 - $100,000	2020-12-17
K. Michael Conaway	🏢 House	$DGRO	▲ Buy	$15,001 - $50,000	2020-11-30
K. Michael Conaway	🏢 House	$DGRO	▲ Buy	$50,001 - $100,000	2020-08-10
K. Michael Conaway	🏢 House	$DGRO	▲ Buy	$15,001 - $50,000	2020-04-22
K. Michael Conaway	🏢 House	$DGRO	▲ Buy	$1,001 - $15,000	2020-04-06
K. Michael Conaway	🏢 House	$DGRO	▲ Buy	$15,001 - $50,000	2020-04-06

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDOFDGRO

Forward yield	4.00% ✓	2.10%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$25.9K	$31.6K ✓
Annual income after 10y	$517.11 ✓	$235.38
Total dividends collected	$4.6K ✓	$2.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MEDOF vs DGRO ($10,000, DRIP)

Year	MEDOF Portfolio	MEDOF Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$11,100	$400.00	$11,290	$209.57	$190.00 → DGRO
2	$12,292	$414.95	$12,722	$213.54	$430.00 → DGRO
3	$13,582	$429.45	$14,314	$217.18	$732.00 → DGRO
4	$14,976	$443.47	$16,080	$220.53	$1.1K → DGRO
5	$16,481	$457.01	$18,040	$223.59	$1.6K → DGRO
6	$18,105	$470.04	$20,215	$226.40	$2.1K → DGRO
7	$19,855	$482.57	$22,627	$228.96	$2.8K → DGRO
8	$21,739	$494.59	$25,302	$231.31	$3.6K → DGRO
9	$23,767	$506.10	$28,268	$233.44	$4.5K → DGRO
10	$25,948	$517.11	$31,557	$235.38	$5.6K → DGRO

MEDOF vs DGRO: Complete Analysis 2026

MEDOF — Stock

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Full MEDOF Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this MEDOF vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDOF vs SCHD MEDOF vs JEPI MEDOF vs O MEDOF vs KO MEDOF vs MAIN MEDOF vs VIG MEDOF vs NOBL MEDOF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.